EvolutionaryScale stock
Private-market facts for current and former EvolutionaryScale employees researching their stock.
Overview
AI biology company developing large language models for proteins to enable programmable biology and accelerate drug discovery.
Selling EvolutionaryScale shares
Why shareholders consider selling
Shareholders in EvolutionaryScale may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, EvolutionaryScale does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell EvolutionaryScale stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Artificial Intelligence sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing EvolutionaryScale shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of EvolutionaryScale shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Artificial Intelligence market conditions, and any recent private-market transaction activity. Data points such as the company's Series A round can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for EvolutionaryScale shareholders
Exploring equity in EvolutionaryScale often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
EvolutionaryScale most recently raised a Series A round in June 2024. Total funding raised to date is approximately $142M.
Lead investors in this round include Amazon and Nvidia.
Founders & company background
EvolutionaryScale was founded in 2023 by Alexander Rives and is headquartered in New York, NY.
Investors
Industry
Similar private companies
Latest EvolutionaryScale news
Frequently asked questions
- Is EvolutionaryScale still a private company?
- Yes, EvolutionaryScale is currently a private company.
- What is EvolutionaryScale's latest funding round?
- EvolutionaryScale's most recent known round is Series A, raised in June 2024.
- What is EvolutionaryScale's valuation?
- EvolutionaryScale's valuation has not been publicly disclosed.
- Who are the investors in EvolutionaryScale?
- Notable investors include Amazon, Nvidia, Lux Capital.
- Can I sell my EvolutionaryScale stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands EvolutionaryScale stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · EvolutionaryScale data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.